logo
EN 简
Company Introduction

Founded in 2018, Belief BioMed is aiming to become a globally leading gene therapy company by being committed to providing innovative therapies with improved efficacy for monogenic disorder diseases, age-related degenerative diseases, and certain malignant diseases through its AAV vector technology from early discovery to commercialization. The R&D and production strengths of Belief BioMed have been recognized by top investment institutions and enterprises. Belief BioMed has offices, research centers and manufacturing facilities in Shanghai, Hong Kong, Beijing and Suzhou China and North Carolina US.

13000

m2 Production and Research Base

300

m2 Non-human Primate Experiment Center

17000

m2 GMP Production Facility

Science & Pipeline

In the deepest despair, you will see the most beautiful stars of hope

Scientific Platform
Manufacturing
Diseases
Pipeline
Recent News
Belief BioMed’s Second AAV-based Gene Therapy Drug Candidate was Granted Orphan Drug Designation by the FDA

2022-12-22

The Case Report of Belief BioMed’s Hemophilia B Gene Therapy Drug Candidate BBM-H901 Published in The New England Journal of Medicine

2022-10-27

Belief BioMed’s AAV-based Gene Therapy Drug Candidate Receives China CDE’s Breakthrough Therapy Designation

2022-08-24

Belief BioMed’s AAV-based Gene Therapy Drug Candidate was Granted Orphan Drug Designation by the FDA

2022-08-17

Belief BioMed Co-Founder and CEO Dr. Jane Zheng was Selected by Forbes as One of the "50 Chinese Women in Science and Technology"!

2022-06-22

Clinical Trial Results of Belief BioMed's Hemophilia B Gene Therapy Drug Candidate BBM-H901 Published in The Lancet Haematology

2022-05-20

Investor Relations
Click to Enter arrow
Careers

We are looking for colleagues who own the common values and goals to create the bright future of BBM and benefit the patients.

We are dedicated to building a working environment that keeps our team inspired and valued. 

Click to Enter arrow
Honor List
2022 SHANGHAI CORE TECHNOLOGY ENTERPRISES 100 LIST
2022 FUTURE MEDICAL 100 LIST
KPMG China Biotechnology Innovation 50 List
2021 CHINA HEALTHCARE INDUSTRY INVESTMENT AND FINANCING HONOR 50 LIST